Philippines
+918265041513
+918265041513

Acriptega – Dolutegravir, Lamivudine & Tenofovir Fumarate Tablets (50-300-300 mg)

Active Ingredients: Dolutegravir 50 mg, Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg Strength: Fixed-dose combination 50/300/300 mg Brand Equivalent: Triumeq Manufacturer: [Manufacturer Name] Exported By: Unnati Pharmax πŸ’Š Product Overview Acriptega is a potent fixed-dose combination tablet containing Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate, used for the treatment of HIV-1 infection. Manufactured under stringent quality standards, Acriptega is an export-grade formulation therapeutically equivalent to Triumeq, providing comprehensive once-daily antiretroviral therapy in a single tablet. This combination works synergistically to inhibit HIV replication at multiple stages of the viral life cycle, helping to reduce viral load, maintain immune function, and prevent disease progression. Globally trusted for its efficacy, Acriptega meets GMP standards and ensures consistent therapeutic outcomes. ⭐ Key Features βœ… Fixed-dose combination: Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg βœ… Potent triple antiretroviral therapy in a single tablet βœ… Manufactured under strict GMP guidelines βœ… Export-quality formulation with proven clinical effectiveness βœ… Convenient once-daily oral tablet dosage βœ… Reduces viral replication and supports immune system function βœ… High-quality, internationally recognized formulation 🩺 Indications & Uses Acriptega is indicated for: βœ… Treatment of HIV-1 infection in adults and adolescents βœ… Patients requiring combination antiretroviral therapy for viral suppression βœ… Suitable for treatment-naΓ―ve and treatment-experienced HIV patients βš™οΈ Mechanism of Action Dolutegravir: Integrase strand transfer inhibitor (INSTI) that prevents viral DNA integration into host cells Lamivudine: Nucleoside reverse transcriptase inhibitor (NRTI) that blocks viral RNA conversion to DNA Tenofovir Disoproxil Fumarate: Nucleotide reverse transcriptase inhibitor (NtRTI) that inhibits viral DNA synthesis This triple mechanism effectively suppresses HIV replication and helps maintain long-term immune system health. ⚠️ Dosage & Administration Administered orally once daily, with or without food Standard dose: 1 tablet daily or as prescribed by a healthcare professional Dosage may be adjusted based on patient condition and tolerance
 2025-11-22T04:46:53

Keywords